OraSure Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference
BETHLEHEM, Pa., Jan. 08, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 38TH Annual J.P. Morgan Healthcare Conference. The conference will be simultaneously webcast over the Internet.
Dr. Tang is scheduled to speak on January 15, 2020, at approximately 4:00 PM Pacific Time (7:00 PM Eastern Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link: https://jpmorgan.metameetings.net/events/hc20/sessions/29646-orasure-technologies-inc/webcast
About OraSure Technologies
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries (DNA Genotek, CoreBiome, Diversigen and Novosanis), OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.
Roberto Cuca Jeanne Mell Chief Financial Officer VP Corporate Communications 610-882-1820 484-353-1575 Investorinfo@orasure.com firstname.lastname@example.org www.orasure.com www.orasure.com